{"slug":"sumitomo-dainippon-pharma","name":"스미토모파마","name_en":"Sumitomo Dainippon Pharma","ticker":"4506.T","updated_at":"2026-07-11T10:21:16.781+00:00","canonical":"https://valuechain.wiki/sumitomo-dainippon-pharma","kicker":"닛케이 225","kicker_en":"Nikkei 225","lead":"정신신경계와 항암 치료제를 개발하는 일본의 제약 기업이다. 닛케이 225 구성종목. 밸류체인 관계·수치 데이터는 조사 전인 기본 노드로, AI 질문 수요가 관측되면 상세 노드로 승격된다.","lead_en":"A Japanese pharmaceutical company developing psychiatric-neurological and oncology treatments. Nikkei 225 constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.","segments":{"parts":[{"name":"의약품"}],"total":"약 ¥3,200억 (FY2024)"},"segments_en":{"parts":[{"name":"Pharmaceuticals"}],"total":"~¥320B (FY2024)"},"returns_yearly":{"2021":-25.5,"2022":-25.1,"2023":-51.9,"2024":40.6,"2025":276.6,"2026":-39.1},"return_asof":"2026-07-10","value_chain":{"leading":[],"benefiting":[],"analysis":null,"analysis_en":null,"analysis_asof":null},"edges":[]}